[Clinical studies with tablets combining lysozyme, papain and bacitracin].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001414:Bacitracin / Q000627:therapeutic use*; D002613:Cheilitis / Q000188:drug therapy; D002648:Child; D002986:Clinical Trials as Topic; D005260:Female; D005891:Gingivitis / Q000188:drug therapy; D005892:Gingivitis, Necrotizing Ulcerative / Q000188:drug therapy; D005928:Glossitis / Q000188:drug therapy; D006801:Humans; D008010:Lichen Planus / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009059:Mouth Diseases / Q000188:drug therapy*; D009113:Muramidase / Q000627:therapeutic use*; D010206:Papain / Q000627:therapeutic use*; D012466:Salivary Gland Diseases / Q000188:drug therapy; D013280:Stomatitis / Q000188:drug therapy; D013281:Stomatitis, Aphthous / Q000188:drug therapy; D014081:Tooth Extraction
D001414:Bacitracin; D009113:Muramidase; D010206:Papain
Expérimentation clinique de comprimés associant lysozyme, papaïne et bacitracine.